CMS
-

HHS, CMS Report Over 1 Million Obamacare Enrollees Lack Social Security Numbers
Health officials report over 1 million Obamacare enrollees lack Social Security numbers, citing concerns over systemic fraud and unauthorized account creation.
-

New Federal Rule Tightens Medicaid ‘Medically Frail’ Exemption Criteria
New CMS guidance mandates that Medicaid enrollees must prove their medical condition prevents them from working to qualify for exemptions, sparking concern from patient advocacy groups.
-

Dr. Oz’s Armenian Community Fraud Claims Draw Civil Rights Complaint
California Governor Gavin Newsom has filed a civil rights complaint against Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, following a video where Oz linked Armenian-owned businesses in Los Angeles to large-scale healthcare fraud. The claims…
-

UnitedHealth Shares Plummet as Trump Administration’s Medicare Rate Proposal Shakes Health Sector
UnitedHealth Group’s stock plunged nearly 20% on Tuesday, dragging down the Dow Jones Industrial Average, after the Trump administration proposed a significantly lower-than-expected increase in Medicare Advantage payment rates for 2027.
-

CMS Schools Face Legal Battle Over Free Speech and Weather Disruptions
Charlotte-Mecklenburg Schools (CMS) are under legal and operational scrutiny: a federal lawsuit alleges censorship after a student’s tribute to Charlie Kirk was erased, while widespread weather disruptions test the district’s emergency response.
-

CMS Announces Major Price Cuts for 15 Top Medicare Drugs Under IRA: What It Means for Patients and Pharma
The Centers for Medicare & Medicaid Services (CMS) has unveiled substantial price reductions for 15 high-cost Medicare drugs under the Inflation Reduction Act (IRA), promising significant savings for patients and taxpayers. These changes, effective from January 2027, have sparked questions…
-

Medicare Drug Price Negotiations to Continue, with Focus on Transparency
The Centers for Medicare & Medicaid Services (CMS) has announced it will proceed with Medicare drug price negotiations under the current administration, emphasizing a commitment to greater transparency in the process. This second round of negotiations will include high-profile, expensive…

